Less calcemic Vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the vasculature

Journal of Steroid Biochemistry and Molecular Biology

Volumn 101, Issue 4-5, 2006, Pages 232-238

  Somjen, Dalia ^a,b   Posner, Gary H ^c   Stern, Naftali ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Aorta; Creatine kinase; Heart; Vitamin D; Vitamin D analogs

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CREATINE KINASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; JFK 1624F2 2; JKF 1624F2 2; QW 1624F2 2; RALOXIFENE; SEX HORMONE; TAMOXIFEN; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; ENERGY BALANCE; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SPECIFICITY; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE METABOLISM; HORMONAL REGULATION; HORMONE RESPONSE; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; OVARIECTOMY; PHARMACODYNAMICS; RAT; UPREGULATION; VASCULARIZATION;

ANIMALS; AORTA; CALCIUM; CREATINE KINASE; DRUG INTERACTIONS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GONADS; MALE; MOLECULAR STRUCTURE; MYOCARDIUM; RALOXIFENE; RATS; RATS, WISTAR; VITAMIN D;

ANIMALIA;

EID: 33750018559     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.06.023     Document Type: Article

References (26)

1. Norman P.E., and Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 39-46
2. 3 is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110 (2002) 229-238
3. Holick M.F. Sunlight and Vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80 Suppl (2004) 1678S-1688S
4. 3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ. Res. 91 (2002) 17-24
5. Jespersen B., Randlov A., Abrahamsen J., Fogh-Andersen N., Olsen N., and Kanstrup I. Acute cardiovascular effect of 1,25-dihydroxycholecalciferol in essential hypertension. Am. J. Hypertens. 11 (1998) 659-666
6. 3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98 (1998) 1302-1306
7. 3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 42 (1991) 127-136
8. Somjen D., Kohen F., Amir-Zaltsman Y., Knoll E., and Stern N. Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. Am. J. Hypertens. 13 (2000) 396-403
9. Somjen D., Kohen F., Gayer B., Knoll E., Limor R., Baz M., Sharon O., Posner G.H., and Stern N. A non-calcemic Vitamin D analog modulates both nuclear and putative membranal estrogen receptors in cultured human vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 397-399
10. Somjen D., Katzburg S., Baz M., Stern N., and Posner G.H. Modulation of the response to estradiol-17beta of rat vascular tissues by a non calcemic Vitamin D analog. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 339-341
11. Kensler T.W., Dolan P.M., Gange S.J., Lee L.-K., Wang Q., and Posner G. Conceptually new deltanoids (Vitamin D analogs) inhibit multistage skin tumorigenesis. Carcinogenesis 21 (2000) 1341-1345
12. Posner G.H., Jeon H.B., Sarjeant A., Riccio E.S., Doppalapudi R.S., Kapetanovic I.M., Saha U., Dolan P., and Kensler T.W. Low-calcemic, efficacious, 1alpha,25-dihydroxyVitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry. Steroids 69 (2004) 757-762
13. Posner G.H., Lee S.H., Kim H.J., Peleg S., Dolan P., and Kensler T.W. Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation. Bioorg. Med. Chem. 13 (2005) 2959-2966
14. 3 synthesis and preliminary biological evaluation. J. Med. Chem. 41 (1998) 3008-3014
15. Dixon K.M., Deo S.S., Wong G., Slater M., Norman A.W., Bishop J.E., Posner G.H., Ishizuka S., Halliday G.M., Reeve V.E., and Mason R.S. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J. Steroid Biochem. Mol. Biol. 97 (2005) 137-143
16. Somjen D., Kaye A.M., Harell A., and Weisman Y. Modulation by Vitamin D status of the responsiveness of rat bone to gonadal steroids. Endocrinology 125 (1989) 1870-1876
17. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Nascimben L., Ingwall J.S., Pauletto P., Friedrich J., Gwathmey J.K., Saks V., Pessina A.C., and Allen P.D. Creatine kinase system in failing and nonfailing human myocardium. Circulation 94 (1996) 1894-1901
19. Weishaar R.E., Kim S.N., Saunders D.E., and Simpson R.U. Involvement of Vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am. J. Physiol. 258 (1990) E134-E142
20. O'Connell T.D., and Simpson R.U. 1,25-Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart. Biochem. Biophys. Res. Commun. 213 (1995) 59-65
21. Somjen D., Weisman Y., Kohen F., Gayer B., Limor R., Sharon O., Jaccard N., Knoll E., and Stern N. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111 (2005) 1666-1671
22. Somjen D., Waisman A., Weisman Y., and Kaye A.M. Non-hypercalcemic" analogs of 1α,25-dihydroxy Vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs. J. Steroid Biochem. Mol. Biol. 72 (2000) 79-88
23. Katzburg S., Hendel D., Waisman A., Posner G.H., Kaye A.M., and Somjen D. Treatment with non-hypercalcemic analogs of 1,25-dihydroxy Vitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts. J. Steroid Biochem. Mol. Biol. 88 (2004) 213-219
24. Guzey M., Luo J., and Getzenberg R.H. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells. J. Cell. Biochem. 93 (2004) 271-285
25. 3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin. Cancer Res. 6 (2000) 3371-3379
26. Stoica A., Saceda M., Fakhro A., Solomon H.B., Fenster B.D., and Martin M.B. Regulation of estrogen receptor-alpha gene expression by 1,25-dihydroxy Vitamin D in MCF-7 cells. J. Cell. Biochem. 75 (1999) 640-651